Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Immunohistochemistry of Cancers Publisher



Ghanadan A1, 2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Dermatopathology, Razi Dermatology Hospital, Vahdate Eslami Ave, Tehran, Iran
  2. 2. Department of Pathology, Cancer Institute, Imam Khomeini Complex Hospital, School of Medicine, Tehran University of Medical Sciences, Keshavarz Blvd, Tehran, Iran

Source: Cancer Immunology: A Translational Medicine Context Published:2015


Abstract

This chapter provides an overview of mostly malignant tumors of various organs with focus on the most common types. The authors have used their own experience in addition to literature review and have discussed the most common and useful immunohistochemistry markers in the diagnosis and differential diagnosis of various malignant tumors. Novel prognostic markers are also included. © Springer-Verlag Berlin Heidelberg 2015.
Related Docs
View other Related Docs
1. Immunohistochemistry of Cancers, Cancer Immunology: A Translational Medicine Context# Second Edition (2020)
2. Hurdles in Cancer Immunotherapy, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)
3. Understanding the Tumor Microenvironment for Effective Immunotherapy, Medicinal Research Reviews (2021)
4. Cancer Immunology, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)
5. Targeting Regulatory T Cells by Curcumin: A Potential for Cancer Immunotherapy, Pharmacological Research (2019)
6. Genetic and Epigenetic Alterations in Parathyroid Neoplasms, Iranian Journal of Pathology (2022)
7. Cancer Immunology, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)
8. Cancer Immunoprevention: Current Status and Future Directions, Archivum Immunologiae et Therapiae Experimentalis (2021)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (10)
Hamid Reza Mirzaei (1)
Other Related Docs
9. Adenoid Cystic Carcinoma and Polymorphus Adenocarcinoma: An Immunohistochemical Comparison, Iranian Journal of Science and Technology# Transaction A: Science (2021)
10. An Agent-Based Model of Avascular Tumor Growth: Immune Response Tendency to Prevent Cancer Development, Simulation (2017)
11. Tumor Antigens, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)
12. The Paradox of Th17 Cell Functions in Tumor Immunity, Cellular Immunology (2017)
13. Natural Killer Cells and Acute Myeloid Leukemia: Promises and Challenges, Cancer Immunology# Immunotherapy (2022)
14. Tumor-Infiltrating Lymphocyte Therapy for Lung Cancer and Its Future Paradigms, Expert Opinion on Biological Therapy (2022)
15. Tumor Antigens, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)
16. Interdigitating Dendritic Cell Tumor of Submandibular Lymph Node: Case Report and Literature Review, Iranian Journal of Pathology (2021)
17. P16ink4a Immunohistochemistry As a Gold Standard for Cervical Cancer and Precursor Lesions Screening, Iranian Journal of Public Health (2020)
18. Cancer Nanomedicine: Special Focus on Cancer Immunotherapy, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)
19. Dysregulation of Helper T Lymphocytes in Esophageal Squamous Cell Carcinoma (Escc) Patients Is Highly Associated With Aberrant Production of Mir-21, Immunologic Research (2019)
20. Image-Based Multiplex Immune Profiling of Cancer Tissues: Translational Implications. a Report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer, Journal of Pathology (2024)
21. The Role of Cxc Chemokines and Receptors in Breast Cancer, Clinical and Experimental Medicine (2025)
22. Cell-Based Vaccines: Frontiers in Medical Technology for Cancer Treatment, Regenerative Engineering and Translational Medicine (2024)
23. Applications of Innovation Technologies for Personalized Cancer Medicine: Stem Cells and Gene-Editing Tools, ACS Pharmacology and Translational Science (2023)
24. Myeloid-Derived Suppressor Cells in Gastrointestinal Cancers: A Systematic Review, Journal of Gastroenterology and Hepatology (Australia) (2016)